This notion is also supported by our observation of a strong EMT induction and expression of fibronectin (α5β1 integrin ligand) in cell aggregates in patient ascites or tumor stroma, and an increasing portion of tumors with active FAK with tumor stage or in distant metastasis (Figures 2 and 5). This evidence concerns the gene FN1 and neoplasm.